Get Ready for AAO 2022: Axim Biotechnologies’ Point-of-Care Diagnostic Test Platform Sales Begin with Versa Ophthalmics’ Commercial Launch!
Sales of Point-of-Care Diagnostic Tests for Ocular Surface Disease Commence at the American Academy of Ophthalmology Annual Meeting Exclusive Partnership for AXIM Biotechnologies, Inc. SAN DIEGO, Sept. 29, 2022 (GLOBE NEWSWIRE) — AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting ocular surface diseases, announced today that…